Contact
Please use this form to send email to PR contact of this press release:
AntriaBio Announces First Patient Dosed in Phase 1 Clinical Study of AB101
TO:
Please use this form to send email to PR contact of this press release:
AntriaBio Announces First Patient Dosed in Phase 1 Clinical Study of AB101
TO: